DIAGNOSTIC TEST
BATTERY FOR
DIFFERENT AGE
GROUPS
Introduction
◦ The American Academy of Audiology supports early identification, assessment, and
intervention for all types of hearing loss in infants and young children to minimize
deleterious effects on speech, language, education, and social/psychological development.
◦ These Clinical Practice Guidelines describe recommended practices for the assessment of
auditory function in children.
◦ The most appropriate protocol will be individualized for each child based on his or her
developmental and/or chronological age and other relevant factors. Thus, test procedures
needed to address this population are diverse.
◦ The scope-of-practice and responsibility of the audiologist is to determine the
appropriate test procedures to use for each child.
◦ The Pediatric Hearing Assessment Task Force has delineated the following areas that make up the pediatric
audiologic assessment test battery:
◦ • Behavioral observation
◦ • Visual Reinforcement Audiometry (VRA)
◦ • Conditioned Play Audiometry (CPA)
Frequency-specific stimuli
Speech Audiometry
◦ Physiologic Assessments,
Acoustic Immittance, including tympanometry and acoustic reflex testing
Otoacoustic Emission (OAE) testing
◦ Electrophysiologic Audiometry including
Auditory Brainstem Response (ABR)
Auditory Steady State Response (ASSR) audiometry
Behavioral Observation
◦ Test Name: The term “audiometry” should be reserved for tests of hearing ability. Because this procedure does not
result in the determination of hearing thresholds, the term Behavioral Observation Audiometry or BOA is not
appropriate, and the preferred term is Behavioral Observation.
◦ Purposes: To assist in the determination of global auditory skill development. This method is inappropriate for
hearing screening or estimating auditory thresholds, or for selecting, modifying or verifying amplification.
◦ Populations Intended: 0-6 months
Visual Reinforcement Audiometry
◦ Test Name: Visual Reinforcement Audiometry (VRA)
◦ Purposes: Used to estimate frequency- and ear-specific hearing sensitivity and hearing loss type using a
conditioned response procedure.
◦ Populations Intended: 6-30 months
Conditioned Play Audiometry
◦ Test Name: Conditioned Play Audiometry (CPA)
◦ Purposes: To determine ear-specific and frequency-specific hearing sensitivity.
◦ Populations Intended: 30months – 4 years
Speech Audiometry
◦ Test names: Speech perception, speech audiometry
◦ Purpose: To determine ability to perceive speech or speech-like stimuli;
to aid in determination of pure tone threshold reliability;
includes speech awareness, speech discrimination, and speech recognition determinations
◦ Population Intended: children at and above approximately 6 months developmental age
Pediatric Immittance Testing
◦ Test names: Tympanometry and Acoustic Reflex Measures
◦ Purpose: To assess middle ear function and auditory pathway integrity; to evaluate for otitis media and other
middle ear abnormalities.
◦ Population intended: Infants and young children. Immittance assessment should occur routinely as a component of
the hearing evaluation, and more frequently for children at increased risk for middle ear disease or for those with
known sensorineural hearing loss, or at risk for auditory neuropathy
Otoacoustic Emissions
◦ Test name: Otoacoustic Emissions (OAEs). Currently, two types of evoked OAEs are used for clinical assessment:
transient-evoked OAEs (TEOAEs), elicited using an acoustic click or other short transient, and distortion product
OAEs (DPOAEs), elicited by the simultaneous presentation of two pure tones.
◦ 2. Purpose: To assess cochlear/outer hair cell function. Although not a direct measure of hearing, OAEs provide
information about the status of the auditory periphery and, in the absence of middle ear disorder, the likelihood of
sensory hearing loss. OAEs can be used as a screening procedure for hearing loss in neonates and infants, a cross-
check verification of behavioral testing when indicated, and/or to establish some aspects of cochlear function in
children with neural hearing loss. OAEs can also be used to monitor cochlear function in children undergoing
potentially ototoxic treatments (e.g., chemotherapy, aminoglycoside antibiotic therapy), although currently there
are no universally established criteria for the degree of change in OAEs considered to be clinically significant.
◦ 3. Population intended: Infants and children of all ages.
Electrophysiologic (EP) Evaluation
◦ Test names: Tone-burst (TB)-Auditory Brainstem Response (ABR) and Auditory Steady-State Response (ASSR).
◦ Purpose: To determine presence and type of hearing loss, and to estimate hearing levels for individual frequencies
in each ear.
◦ Population intended: Newborns and infants; a child of any age who is incapable of providing accurate information
for behavioral tests or who has yielded behavioral test results that are not reliable or are incomplete.
THANK YOU !!
